ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for December 2017

IASLC 18th WCLC Special Session Provides Overview of Updated Guidelines for Molecular Testing

on: December 18, 2017In: Evolving Standards of Care
IASLC 18th WCLC Special Session Provides Overview of Updated Guidelines for Molecular Testing

Posted: December 2017 Experts in molecular testing discussed various issues on this topic in October at the IASLC 18th WCLC. Neal Lindeman, MD, led off the session with an overview […] Read more


IASLC Consensus Statement on Liquid Biopsy

on: December 18, 2017In: Evolving Standards of Care
IASLC Consensus Statement on Liquid Biopsy

By Christian Rolfo, MD, PhD, MBAh, and Philip C. Mack, PhD Posted: December 2017 In just the past decade, tremendous advancements in the treatment of metastatic non-small cell lung cancer […] Read more

Studies Indicate Expanding Benefit of Checkpoint Inhibitors

on: December 18, 2017In: Meeting News
Studies Indicate Expanding Benefit of Checkpoint Inhibitors

By Cynthia L. Kryder, MS and Lori L. Alexander, MTPW, ELS, MWC Posted: December 2017 An oral abstract session at the IASLC World Conference on Lung Cancer (WCLC) 2017 drew […] Read more

Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru

on: December 18, 2017In: Meeting News
Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru

By Luis E. Raez, MD Posted: December 2017 Under the sponsorship of the IASLC, the Peruvian Association for Bronchology and Interventional Pulmonology (APBNI) organized a seminar on bronchoscopy ultrasound (EBUS) […] Read more

Cannabis, Lung Cancer, and Therapy

on: December 18, 2017In: Supportive & Palliative Care
Cannabis, Lung Cancer, and Therapy

By Emily Stone, MBBS, MMed, FRACP, and James Jett, MD Posted: December 2017 Cannabis, a generic term for various products derived from the plant cannabis sativa, has a long history […] Read more

Discussing ALCHEMIST with Dr. Shakun Malik

on: December 18, 2017In: Regulatory Agency Perspective
Discussing ALCHEMIST with Dr. Shakun Malik

Posted: December 2017 Patients with completely resected early-stage non-small cell lung cancer (NSCLC) have approximately a 50% chance of experiencing disease recurrence following standard treatment. In 2014, the NCI initiated […] Read more

IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology

on: December 18, 2017In: Meeting News
IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology

By Jyoti Patel, MD, and Heather A. Wakelee, MD Posted: December 2017 The IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology was held September 14-16, 2017 and brought together nearly […] Read more

INFORMED: An Interview with Sean Khozin, MD, MPH

on: December 18, 2017In: Regulatory Agency Perspective
INFORMED: An Interview with Sean Khozin, MD, MPH

Posted: December 2017 The Information Exchange and Data Transformation (INFORMED) initiative was launched by the U.S. Food and Drug Administration (FDA) and the Innovation, Design, Entrepreneurship and Action (IDEA) Lab […] Read more

Patients with EGFR Mutation Should Postpone Brain Radiation for CNS Metastases: Pro and Con

on: December 18, 2017In: Radiation Oncology
Patients with EGFR Mutation Should Postpone Brain Radiation for CNS Metastases: Pro and Con

By Pranshu Mohindra, MD, MBBS, DABR®, Lecia Sequist, MD, and Laurie E. Gaspar, MD, MBA Posted: December 2017 Since the initial approval of erlotinib, an oral tyrosine kinase inhibitor (TKI), […] Read more

Commentary Regarding Immune Checkpoint Inhibitors

on: December 18, 2017In: Uncategorized
Commentary Regarding Immune Checkpoint Inhibitors

By Fabrice Barlesi, MD, PhD Posted: December 2017 Since the advent of adjuvant platinumbased chemotherapy as the standard of care, little progress has been achieved in significantly improving the cure […] Read more

123

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy